Evotec SE - Company Profile
Powered by
All the data and insights you need on Evotec SE in one report.
- Save hours of research time and resources with
our up-to-date Evotec SE Strategy Report
- Understand Evotec SE position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Evotec SE (Evotec) is a drug discovery alliance and development partnership company. It discovers and develops small molecule drugs spanning various conditions areas such as oncology, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory diseases. Evotec provides drug discovery services such as target identification and validation, sample management, hit identification, in vitro pharmacology services, integrated CMC, and proteomics services. The company has long-term discovery alliances with several leading pharmaceutical companies and development partnerships for product candidates in clinical and pre-clinical development stages. The company has operating facilities in Abingdon and Alderley Park, the UK; Gottingen and Munich, Germany; Orth an der Donau, Austria; Branford, Princeton and Watertown, the US; Verona, Italy; and Toulouse and Lyon, France. Evotec is headquartered in Hamburg, Germany.
Evotec SE premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Technologies: | Drug Discovery | J. DISCOVERY |
J. DESIGN | Target Identification and Validation | J. MD |
Induced Pluripotent Stem Cells (IPSC) Drug Discovery Platform | Hit Identification | J.POD |
XYZ | XYZ | |
XYZ | XYZ | |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In April, the company entered into an agreement with Variant Bio, Inc. to identify a best-in-class treatment for diseases caused by fibrosis. |
2024 | Contracts/Agreements | In March, the company secured a contract to provide winch equipment for a Faroese fishing vessel ordered by Vardin from the MEST yard in Torshavn, Faroe Islands. |
2024 | Contracts/Agreements | In February, Just – Evotec Biologics, Inc. expanded its contract with Advanced BioScience Laboratories, Inc. to design highly efficient manufacturing processes for neutralising antibodies against HIV. |
Competitor Comparison
Key Parameters | Evotec SE | Merck & Co Inc | AstraZeneca Plc | Cobra Biologics Ltd | Charles River Germany GmbH & Co. KG |
---|---|---|---|---|---|
Headquarters | Germany | United States of America | United Kingdom | United Kingdom | Germany |
City | Hamburg | Kenilworth | Cambridge | Keele | - |
State/Province | Baden-Wurttemberg | New Jersey | England | Staffordshire | - |
No. of Employees | 5,086 | 72,000 | 89,900 | 134 | - |
Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Laetitia Rouxel | Director; Chief Financial Officer | Executive Board | 2023 | - |
Craig Johnstone, Ph.D. | Chief Operating Officer | Senior Management | 2019 | 53 |
Cord Dohrmann, Ph.D. | Chief Scientific Officer | Senior Management | 2010 | 59 |
Mario Polywka | Chief Executive Officer - Interim | Senior Management | 2024 | - |
Iris Low-Friedrich | Vice Chairman | Executive Board | 2019 | 63 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward